Loading…
S. 4440119th CongressIn committeeLatest action Apr 29, 2026Decoded by AI · checked against the record
Official title: A bill to modernize clinical trials and remove barriers for participation in clinical trials, and for other purposes.
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
S 4440 lets companies cover clinical trial costs for participants and excludes up to $2,000/year in trial payments from taxable income.
50-second read · 5 questions answered below
This bill changes federal rules so drug and device companies can legally pay participants' medical costs, travel, meals, and provide free digital health tools during clinical trials. It also excludes up to $2,000 per year in trial payments from a participant's taxable income. Federal grants would fund outreach and education in multiple languages to recruit more diverse participants and investigators.
People from rural communities, tribal areas, and lower-income backgrounds are specifically named as groups this bill aims to reach. Drug, device, and vaccine companies, as well as clinical trial investigators, are also affected.
Without this bill, out-of-pocket costs and lack of support can make it hard for many people to join clinical trials. These changes shift who can realistically participate and how companies are allowed to support them under federal law.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Finance.